December 12, 2016

TOKYO, JAPAN - Dec. 12, 2016 - Terumo Corporation (TSE: 4543) announced today that it has formulated its 5-year Mid- to Long-term Growth Strategy starting from April, 2017. As a global corporation with Japanese origins, we will achieve profitable and sustainable growth by executing the following strategies in a ten-year perspective.

Mid- to Long-term Growth Strategy

1. Win in selected strategic markets

  • Select growing segments and segments where Terumo owns a competitive advantage
  • oncentrate on intervention, neurovascular, D&D, and therapeutic apheresis

2. Offer comprehensive value in Japan

  • Leverage leading position and pursue growth opportunities

3. Accelerate innovation

  • Contribute to future of healthcare with significant social impact
  • Advance core technologies and gain new technologies

Management Indicators for the Next Five Years

(Plan FX rate: USD=105 JPY, EUR=115 JPY)

Growth:

Faster revenue growth than market growth
High single-digit growth in revenue

Profitability:

Faster profit growth than revenue growth
Double-digit growth in profit*
Adjusted EPS** 270 - 300 yen by 2021

Efficiency:

Maintain ROE 10%+***

* Adjusted operating income (IFRS)

** Adjusted items: Intangible asset derived from acquisition, one time acquisition expense, impairment, gain/loss from sales of stocks and others

***Excluding foreign currency translation adjustment balance related to the assets from acquisition included in net assets

For more information, visit http://www.terumo.com/investor/library/material.html

(Notice) Among the information that Terumo discloses, the forward-looking statements including financial projections are based upon our assumptions using information available to us at the time and are not intended to be guarantees of future events or performance. Accordingly, it should be noted that actual results may differ from those forecasts on projections due to various factors. Factors affecting to actual results include, but are not limited to, changes in economic conditions surrounding Terumo, fluctuations of foreign exchange rates, and state of competition. The market share information in this press release is partly derived from our own independent research.

Terumo Corporation published this content on 12 December 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 12 December 2016 03:50:02 UTC.

Original documenthttp://www.terumo.com/about/pressrelease/2016/20161212.html

Public permalinkhttp://www.publicnow.com/view/07ABD7FABD98CB13986F020632FF067FF6F2AFDF